Search Results 9671-9680 of 33284 for oral
... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...
Prior Oral Contraceptive Use Associated with Better Outcome for Ovarian Cancer Patients. Joe Dangor. November 11, 2015. Cardiovascular. Genetic Risk Information ...
Florida. Mayo Clinic awarded $5.3 million federal grant to study vascular risk factors in dementia. Kevin Punsky. November 12, 2015. Cancer. Prior Oral ...
Subjects will be randomized in a 1:1 ratio to receive oral VS-6063 400 mg twice per day, or matched placebo. Randomization will be stratified by tumor ...
Cancer. Prior Oral Contraceptive Use Associated with Better Outcome for Ovarian Cancer Patients. Joe Dangor. November 11, 2015. Cardiovascular. Genetic Risk ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.